• N/A
    Market Cap
  • -27.26%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.02
$0.02
$0.02
1-Year Range
$0.01
$0.03
$0.02
Latest Close$0.02
Change
-$0.0002 (-0.97%)
Volume76,078

Information as of 08/21/2026

Company Profile

Red Light Holland Corp.
https://www.rhelion.com
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
1 Adelaide Street East, Toronto, ON, Canada, M5C 2V9
647 204 7129

Rhelion Life Sciences Corp. engages in the research and development of psychedelic drug in Netherlands, Canada, and the United States. Its products also include PEX010, a natural psilocybin drug candidate. It also engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe, as well as selection, distribution, and export of truffles. The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026. Rhelion Life Sciences Corp. is based in Toronto, Canada.

Key Executives

  • Todd Michael Shapiro
  • Hans Derix
  • Sarit Hashkes
  • Keith Li
  • Lisa Ranken

Current Ownership Distribution

  • Other419.5M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)